The Austrian Ministry of Health has entered into a preparedness contract with Baxter Healthcare SA, a subsidiary of Baxter International, for an option to purchase 16 million doses of pandemic influenza vaccine. The three-year agreement provides the Austrian MOH with future access to the company’s cell-based vaccine production capacity in the event of an avian flu pandemic. “We are proud to provide the advanced science and technology, manufacturing capability and other resources...